Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2006-11-14
2006-11-14
Channavajjala, Lakshmi (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S423000
Reexamination Certificate
active
07135189
ABSTRACT:
A therapeutic medical article is provided which comprises a medical article, a precursor compound and an activator compound. The medical article is adapted, upon administration to a patient, to release the precursor compound and the activator compound such that the activator compound interacts with the precursor compound and converts the precursor compound into activated form for local delivery. Specific examples of precursor and activator compound pairs include: (a) a nitrosothiol precursor and a nitric oxide donor, (b) plasminogen and plasminogen activator, and (c) fibrinogen and thrombin.
REFERENCES:
patent: 4889722 (1989-12-01), Sheffield et al.
patent: 5116861 (1992-05-01), Goto et al.
patent: 5279565 (1994-01-01), Klein et al.
patent: 5510077 (1996-04-01), Dinh et al.
patent: 5770645 (1998-06-01), Stamler et al.
patent: 5989215 (1999-11-01), Delmotte et al.
patent: 5994444 (1999-11-01), Trescony et al.
patent: 6352710 (2002-03-01), Sawhney et al.
patent: 2002/0022046 (2002-02-01), Tedeschi et al.
patent: 0 567 391 (1993-10-01), None
patent: WO 95/22316 (1995-08-01), None
patent: WO 96/33757 (1996-10-01), None
patent: WO 99/38546 (1999-08-01), None
patent: WO 00/02501 (2000-01-01), None
patent: WO 00/62614 (2000-10-01), None
patent: WO 01/70199 (2001-09-01), None
patent: WO 02/43786 (2002-06-01), None
patent: WO 02/056904 (2002-07-01), None
J.Y. Jeremy et al., “Nitric Oxide and the Proliferation of Vasular Smooth Muscle Cells,” Cardiovasc Res Aug. 15, 1999; 43(3):580-94.
Pulfer, Sharon K. et al., “Incorporation of nitric oxide-releasing crosslinked polyethyleneimine microspheres into vascular grafts,”Journal of Boimedical Materials Research, vol. 37, No. 2, Nov. 1997, pp. 182-189.
Bohl, Kristyn S. et al., “Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation,”Biomaterials, vol. 21, No. 22, Nov. 15, 2000, pp. 2273-2278.
Bult, Hidde, “Restenosis: a challenge for pharmacology,”Trends In Pharmacological Sciences, vol. 21, No. 7, Jul. 2000, pp. 274-279.
Grant, Maria B. et al., “Expression of IGF-1, IGF-1 receptor and TGF-B following balloon angioplasty in atherosclerotic and normal rabbit iliac arteries: An immunocytochemical study,” Regulatory Peptides, vol. 79, No. 1, Jan. 1999, pp. 47-53.
Janero, David R. et al., “Nitric Oxide And Postangioplasty Restenosis: Pathological Correlates and Therapeutic Potenial,”Free Radical Biology&Medicine, vol. 29, No. 12, Dec. 15, 2000, pp. 1199-1221.
Ganaha, Fumikiyo et al., “Efficient inhibition of in-stent restenosis by controlled hybrid stent-based local release of nitric oxide,”Circulation, vol. 104, No. 17 Supplement, Oct. 23, 2001, p. II.506.
Bonham, Esq. David B.
Boston Scientific Scimed Inc.
Channavajjala Lakshmi
Mayer & Williams PC
Park, Esq. Keum J.
LandOfFree
Compositions and techniques for localized therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and techniques for localized therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and techniques for localized therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3705211